Looking for L Cystine Dihydrochloride pharmaceutical excipients? Find information on L Cystine Dihydrochloride's applications, manufacturers, suppliers, etc. on PharmaCompass.

PharmaCompass

FINISHED DOSAGE FORMULATIONS

Upload your portfolio for free, ask us

FDF DOSSIERS SUPPLIERS

read-more
read-more

01

arrow
ISPE Annual Meeting
Not Confirmed
United Kingdom
arrow
ISPE Annual Meeting
Not Confirmed

BUPROPION HYDROCHLORIDE

Drug : BUPROPION HYDROCHLORIDE

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Application Number : 210497

Country : US

Patented : No

blank

02

arrow
ISPE Annual Meeting
Not Confirmed

03

arrow
ISPE Annual Meeting
Not Confirmed
United Kingdom
arrow
ISPE Annual Meeting
Not Confirmed

BUPROPION HYDROCHLORIDE

Drug : ZYBAN

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Application Number : 20711

Country : US

Patented : No

blank

04

arrow
ISPE Annual Meeting
Not Confirmed
United Kingdom
arrow
ISPE Annual Meeting
Not Confirmed

BUPROPION HYDROCHLORIDE

Drug : WELLBUTRIN SR

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Application Number : 20358

Country : US

Patented : No

blank

05

arrow
ISPE Annual Meeting
Not Confirmed
Belgium
arrow
ISPE Annual Meeting
Not Confirmed

TECHNETIUM TC-99M SESTAMIBI KIT

Drug : TECHNETIUM TC 99M SESTAMIBI

Dosage Form : INJECTABLE; INJECTION

Application Number : 78098

Country : US

Patented : No

blank

06

arrow
ISPE Annual Meeting
Not Confirmed
arrow
ISPE Annual Meeting
Not Confirmed

TECHNETIUM TC-99M SESTAMIBI KIT

Drug : TECHNETIUM TC 99M SESTAMIBI

Dosage Form : INJECTABLE; INJECTION

Application Number : 78806

Country : US

Patented : No

blank

07

arrow
ISPE Annual Meeting
Not Confirmed
arrow
ISPE Annual Meeting
Not Confirmed

BUPROPION HYDROCHLORIDE

Drug : BUPROPION HYDROCHLORIDE

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Application Number : 207459

Country : US

Patented : No

blank

08

arrow
ISPE Annual Meeting
Not Confirmed
India
arrow
ISPE Annual Meeting
Not Confirmed

BUPROPION HYDROCHLORIDE

Drug : BUPROPION HYDROCHLORIDE

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Application Number : 90693

Country : US

Patented : No

blank

09

arrow
ACI Convention
Not Confirmed

10

arrow
ISPE Annual Meeting
Not Confirmed
India
arrow
ISPE Annual Meeting
Not Confirmed

BUPROPION HYDROCHLORIDE

Drug : BUPROPION HYDROCHLORIDE

Dosage Form : TABLET; ORAL

Application Number : 207403

Country : US

Patented : No

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty